Page last updated: 2024-08-20

perylene and Synovioma

perylene has been researched along with Synovioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aretz, S; Büttner, R; Friedrichs, N; Hartmann, W; Huss, S; Kawai, A; Kindler, D; Kirfel, J; Koch, A; Larsson, O; Mechtersheimer, G; Michels, S; Penzel, R; Renner, M; Schirmacher, P; Sievers, E; Sonobe, H; Steiner, S; Tanaka, S; Trautmann, M; Waha, A; Wardelmann, E	1

Other Studies

1 other study(ies) available for perylene and Synovioma

Article	Year
SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma. Oncogene, 2014, Oct-16, Volume: 33, Issue:42 Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Cell Nucleus; Cell Survival; Gene Expression; HEK293 Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Oncogene Proteins, Fusion; Perylene; Pyrimidinones; Sarcoma, Synovial; Triazines; Wnt Signaling Pathway; Xenograft Model Antitumor Assays	2014

Article

Year

SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.

Oncogene, 2014, Oct-16, Volume: 33, Issue:42

Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Cell Nucleus; Cell Survival; Gene Expression; HEK293 Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Oncogene Proteins, Fusion; Perylene; Pyrimidinones; Sarcoma, Synovial; Triazines; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2014